Biomarin Pharmaceutical (BMRN) EBITDA (2009 - 2026)
Biomarin Pharmaceutical's EBITDA came in at $208.56 million for Q2 2026, down 29.4% from $295.45 million a year earlier but up 42.8% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) EBITDA (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Biomarin Pharmaceutical reported EBITDA of $302.23 million, down 64.8% year-over-year; for FY2025, it was $489.04 million, down 15.8% from FY2024.
- EBITDA carries a five-year compound annual growth rate of 51.3% (FY2020 to FY2025).
- Going back by year, EBITDA was $580.64 million in FY2024 (+100.1%), $290.16 million in FY2023 (+10.4%), $262.94 million in FY2022 (+923.2%) and $25.7 million in FY2021 (-58.4%).
- The five-year range for quarterly EBITDA is -$39.89 million (Q4 2021) to $295.45 million (Q2 2025).
- Year-over-year, EBITDA increased in four of the last six quarters, with growth averaging 86.9%.
- The fastest year-over-year change in EBITDA over five years came in Q4 2023 (growth of 372.2%), and the weakest in Q1 2023 (a decline of 46.1%).
- Business Quant data shows BMRN's EBITDA at $146.05 million (Q1 2026), -$24.17 million (Q4 2025) and -$28.21 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Biomarin Pharmaceutical | 11.51 Bn | 5.37 Bn | 786.91 Mn | 208.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 208.56 Mn |
| Mar 31, 2026 | 146.05 Mn |
| Dec 31, 2025 | -24.17 Mn |
| Sep 30, 2025 | -28.21 Mn |
| Jun 30, 2025 | 295.45 Mn |
| Mar 31, 2025 | 245.96 Mn |
| Dec 31, 2024 | 185.01 Mn |
| Sep 30, 2024 | 132.90 Mn |
| Jun 30, 2024 | 146.92 Mn |
| Mar 31, 2024 | 115.81 Mn |
| Dec 31, 2023 | 54.14 Mn |
| Sep 30, 2023 | 56.21 Mn |
| Jun 30, 2023 | 90.99 Mn |
| Mar 31, 2023 | 88.83 Mn |
| Dec 31, 2022 | 11.47 Mn |
| Sep 30, 2022 | 22.39 Mn |
| Jun 30, 2022 | 64.42 Mn |
| Mar 31, 2022 | 164.67 Mn |
| Dec 31, 2021 | -39.89 Mn |
| Sep 30, 2021 | -26.38 Mn |
API Access
Biomarin Pharmaceutical EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();